| 2016-17 SALES (IN BILLIONS $ U.S.) | 20.1* |
| FISCAL YEAR-END | Dec. |
| SYSTEMWIDE STORES FISCAL 2016-17 YEAR-END | 9,656 |
| STORE FORMATS | Drug chain |
| BRANDS/CONCEPTS | CVS Pharmacy; CVS; Longs Drugs; Navarro Discount Pharmacy |
| HEADQUARTERS | Woonsocket R.I. |
| KEY EXECUTIVES | Larry J. Merlo / president and CEO |
| FOOTNOTES | Estimated consumables sales for fiscal 2016 ended in December represent the non-prescription-drug share or 25% of estimated total retail pharmacy and long-term care (LTC) business sales of $80.5 billion. The non-prescription-drug share was 27.1% of division sales in fiscal 2015. Store count shown excludes 42 retail pharmacies in Brazil that generated an estimated share of total retail-LTC sales of less than half a percent. In December 2015 acquired 1672 in-store pharmacies from Target Corp. that primarily generate prescription drug sales not counted toward Top 75 consumables sales reporting. CVS total estimated fiscal 2016 net sales from pharmacy services as well as retail-LTC affairs were $177.1 billion. |
